These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1655433)

  • 41. MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.
    Mady RF; El-Temsahy MM; Issa YA; Zaghloul AS; Khedr SI
    Acta Parasitol; 2024 Jun; 69(2):1253-1266. PubMed ID: 38743178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
    Chew WK; Segarra I; Ambu S; Mak JW
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1762-8. PubMed ID: 22271863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical experience on treating Toxoplasma gondii infection during pregnancy by using acetyl spiramycin combined with azithromycin].
    Tang HX; Xiong XF; Qin ZQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Oct; 25(5):555-6. PubMed ID: 24490384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zingiber officinale Ameliorates Acute Toxoplasmosis-Induced Pathology in Mice.
    El-Kady AM; Elshazly H; Alsulami MN; Albohiri HH; Alshehri EA; Alfaifi MS; Mohamed K; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Almalki GH; Abdel-Rahman IAM; Elshabrawy HA; Younis S
    Acta Parasitol; 2024 Sep; ():. PubMed ID: 39225734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae.
    Goldstein FW; Emirian MF; Coutrot A; Acar JF
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():25-8. PubMed ID: 2154434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calibration of an in vitro assay system using a non-adherent cell line to evaluate the effect of a drug on Toxoplasma gondii.
    Bunetel L; Guerin J; Andre P; Robert R; Deunff J
    Int J Parasitol; 1995 Jun; 25(6):699-704. PubMed ID: 7657455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rifapentine is active in vitro and in vivo against Toxoplasma gondii.
    Araujo FG; Khan AA; Remington JS
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1335-7. PubMed ID: 8725996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of Toxoplasma gondii protein synthesis by azithromycin.
    Blais J; Garneau V; Chamberland S
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1701-3. PubMed ID: 8215287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
    Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
    J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.
    Milatovic D
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):33-5. PubMed ID: 2154381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of 2',3'-dideoxyinosine on Toxoplasma gondii cysts in mice.
    Sarciron ME; Lawton P; Saccharin C; Petavy AF; Peyron F
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1531-6. PubMed ID: 9210679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The superior efficacy of chloroquine over buparvaquone in reducing the chronic cerebral Toxoplasma gondii cysts load and improving the ultrastructural pathology in an immunocompromised murine model.
    Fahmy MEA; Abdel-Aal AA; Hassan SI; Shalaby MA; Esmat M; Abdel Shafi IR; Afife AA; Shaheen HAA
    Trop Biomed; 2023 Mar; 40(1):115-123. PubMed ID: 37356011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA; Shafey DA; Selim SM; Sharaf SA; Mohsen KK; Allam DM; Elkhadry SW; Gouda MA
    Parasitol Res; 2024 Jul; 123(7):286. PubMed ID: 39046555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex dichotomy in the course of experimental latent toxoplasmosis.
    Hegazy MM; Elmehankar MS; Azab MS; El-Tantawy NL; Abdel-Aziz A
    Exp Parasitol; 2019 Jul; 202():15-21. PubMed ID: 31078550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii].
    Braz LM; Di Pietro AO; Amato Neto V; França FO
    Rev Soc Bras Med Trop; 1999; 32(4):401-3. PubMed ID: 10495670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
    Almurshidi BH; Fahmy Z; El-Shennawy A; Selim EAH; Hammam OA; Okasha H; Al-Hajj W; Mahmoud SA; Abuelenain GL
    Parasite Immunol; 2023 Dec; 45(12):e13014. PubMed ID: 37807942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of azithromycin against cryptosporidia in immunosuppressed rats.
    Rehg JE
    J Infect Dis; 1991 Jun; 163(6):1293-6. PubMed ID: 1645382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.